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Abstract
Background: Weaning is a period of marked physiological change. The introduction of solid foods and the
changes in milk consumption are accompanied by significant gastrointestinal, immune, developmental, and
microbial adaptations. Defining a reduced number of infections as the desired health benefit for infants around
weaning, we identified in silico (i.e., by advanced public domain mining) infant gut microbes as potential deliverers of
this benefit. We then investigated the requirements of these bacteria for exogenous metabolites as potential prebiotic
feeds that were subsequently searched for in the natural product space.
Results: Using public domain literature mining and an in silico reverse metabolic approach, we constructed probiotic-
prebiotic-food associations, which can guide targeted feeding of immune health-beneficial microbes by weaning food;
analyzed competition and synergy for (prebiotic) nutrients between selected microbes; and translated this information
into designing an experimental complementary feed for infants enrolled in a pilot clinical trial (http://www.
nourishtoflourish.auckland.ac.nz/).
Conclusions: In this study, we applied a benefit-oriented microbiome research strategy for enhanced early-life
immune health. We extended from “classical” to molecular nutrition aiming to identify nutrients, bacteria, and
mechanisms that point towards targeted feeding to improve immune health in infants around weaning. Here,
we present the systems biology-based approach we used to inform us on the most promising prebiotic combinations
known to support growth of beneficial gut bacteria (“probiotics”) in the infant gut, thereby favorably promoting
development of the immune system.
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Background
The human body is host to 1014 resident microorgan-
isms (bacteria, viruses, fungi, and protozoa) [1] that live
in synergy with human cells influencing health outcomes
across lifespan [2]. Depending on micro-environmental
conditions, each body site is colonized by specific micro-
bial communities shaped by co-evolution with the host.
The majority of those microbes live in our gastrointes-
tinal (GI) tract [3]. At birth, the pristine infant gut is
rapidly colonized by millions of bacteria, some benefi-
cial, some not. The first microbial inoculum is acquired
at birth with differences in both diversity and abundance
driven by host genetics, prenatal and maternal factors,
such as the delivery mode, i.e., cesarean or vaginal [4].
The newborn’s microbiome is not yet stable and varies
inter-individually [5]. The changes occur as a conse-
quence of exposure to different environmental and
health/disease conditions, dietary patterns, and also ex-
posure to antibiotics. A diverse and balanced gut micro-
biome provides benefits to the host through affecting
several physiological processes [6] ranging from matur-
ation of the immune system, regulation of host metabol-
ism, response to nutrition, metabolism of bioactive
molecules and drugs [6], biosynthesis of vitamins and
amino acids, and absorption of iron [2].
In the first 1000 days of life, the development of the
infant’s microbiome is intimately tied to maturation of
the immune system [7]. It has long been hypothesized
that microbial exposure in early life has a protective ef-
fect on the newborn’s health and can influence the
health outcomes later in life [4]. The gut microbiota is
required for maturation and maintenance of the immune
system and has a role in modulation of the immune sys-
tem. For example, the immune system-microbiota inter-
action enables induction of protective responses to
pathogens and the maintenance of regulatory pathways
involved in the tolerance to innocuous antigens [8].
While several studies support the role of diet in shap-
ing the gut microbial community in adults, only a few
focused on understanding the contribution of comple-
mentary foods during the weaning period to the modula-
tion of the infant gut microbiome [9]. Weaning is a
phase of marked physiological change. The introduction
of solid foods and the changes in milk consumption trig-
ger significant GI tract, immune and developmental ad-
aptations. Weaning also exposes infants to non-
digestible carbohydrates and provides new substrates for
the microbial gut community with resulting growth and
dominance of some taxa, such as Bacteroides [10], and a
reduction of others, such as bifidobacteria, enterobac-
teria, and some Clostridium spp. [9]. Hence, infant nu-
trition, especially in the complementary feeding period,
exerts profound health impacts and careful dietary inter-
ventions during weaning can support the development
of both a healthy microbiome and immune system,
thereby improving child growth and development [11].
We report on an innovative and integrated pipeline de-
veloped to support complementary feeding design with
the identification of essential metabolites required by
beneficial and protective bacteria (“prebiotic feeds for pro-
biotic bacteria”). After a comprehensive capture of the lit-
erature on the infant gut microbiome, the pipeline drives
the selection of candidate immune-protective infant GI
bacteria. By applying an in silico reverse metabolic ap-
proach, which uses the microbial metabolic network to
infer its nutritional requirements without prior informa-
tion, we mined the microbial metabolism to identify ex-
ogenous compounds required by candidate bacteria,
which were sourced from the chemical composition of
foods in order to enable identification of prebiotic ingredi-
ents naturally present in food and which can be given
safely to infants during weaning. Our systems biology ap-
proach has informed the design and development of a
complementary prebiotic feeding to nourish the micro-
biota that supports the immune system of infants and that
promotes protection against common infections (http://
www.nourishtoflourish.auckland.ac.nz/). Essentially, our
methodology addresses and answers the following ques-
tions: (i) which immune protection-beneficial infant GI
bacteria are present around and after weaning?; (ii) can we
interrogate bacterial metabolism by identifying key en-
zymes involved in exogenous metabolite conversion and
what do these preferred bacteria predominantly feed
(“prebiotics”)?; (iii) is there an interaction for these metab-
olites between the selected bacteria and are essential nu-
trients cross-fed between bacteria?; and (iv) where and
how can “prebiotic” whole foods or food components be
sourced from the food chain?
Results
Identification of immune-protective bacteria (question i)
The core query (Fig. 1) yielded a total of 3673 unique
PubMed IDs by searching titles and abstracts and specif-
ically 1657 PubMed IDs for infant gut microbiome, 608
PubMed IDs for infant nutrition and microbiome metab-
olism, 583 PubMed IDs for beneficial bacteria support-
ing immune system development in infant, and 825
PubMed IDs for beneficial bacteria preventing infections
in infants.
The PubMed IDs shared by single or multiple research
topics are shown in the Venn diagram of Fig. 2.
Fifty PubMed IDs were common to all search criteria.
Available full texts (or abstracts when full texts were not
available) were automatically annotated for cited
biological entities to build dictionaries of relevant terms
for the sentence extraction. As detailed in the Methods
section, for each of the queries (a), (b), (c) and (d), the
pipeline extracted relationships between each pair of the
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four dictionaries and co-mentions of more than two
different dictionaries (Table 1), that were filtered to ob-
tain the final list of sentences (Additional files 1 and 2).
The list of all microbes cited in the extracted sen-
tences for both relationships and co-mentions was then
manually curated (Additional files 1 and 2, “*-species”
sheets). Examples of relevant sentences and associated
PubMed IDs from which the relevant bacterial species
are extracted are given in Additional file 3: Table S1.
We firstly concentrated our efforts on outcomes from
queries (c) beneficial bacteria supporting immune system
development in infants and (d) beneficial bacteria
(a) (b) (c) (d)
Fig. 1 Public domain mining workflow for identifying intestinal bacteria, known or suggested to exert beneficial effects on the infant immune
system. The main scientific concepts for the project were categorized into four research topics: (a) infant gut microbiome, (b) infant nutrition and
microbiome metabolism, (c) beneficial bacteria supporting immune system development in infants, and (d) beneficial bacteria preventing
infections in infants. For each topic, a set of keywords was identified to retrieve all relevant publications from MEDLINE, PubMed, and PubMed
Central. All relevant terms, belonging to the entities: diseases, genes, chemicals, and species, were annotated. Specific dictionaries were then
created selecting all terms relevant for the present study. Sentences showing a relationship between dictionary concepts were extracted from the
texts through natural language processing. The output is a list of sentences with the following related pieces of information: PubMed ID, journal
section, terms in the relationships and, for each dictionary, the list of terms found
Fig. 2 Venn diagram of PubMed IDs showing the number of abstracts found for each research topic and the overlap between them
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preventing infections in infants. Our pipeline recognized
27 unique species names from the relations of both
queries (Additional file 1, “*-species” sheets). Among
those lists, the most frequent species were Lactobacillus
rhamnosus (appearing in 67 and 72 of the 223 and 235
sentences extracted for queries (c) and (d) respect-
ively) and Lactobacillus casei in query (c) (37/223)
and Lactobacillus acidophilus (33/235) in query (d).
Queries (a) infant gut microbiome and (b) infant nu-
trition and microbiome metabolism, which were
expected to collect ecological information on the in-
fant microbiome and metabolism, found again L.
rhamnosus as the most cited species, 77/260 and 15/
60 sentences from query (a) and (b) respectively, and
L. acidophilus (35/260) and Bifidobacterium breve
(12/60) from query (b) as they are known to be infant
gut commensals. As expected, co-mention analysis
produced weaker microbial results after manual cur-
ation (Additional file 2, “*-species” sheets); we ob-
tained a total of 22 species names from query (c) and
24 from query (d) that confirm the main outcomes
from relationships. Based on those lists, the putative
probiotic strains implicated in immune defense
against infections in infants were evaluated and se-
lected: 14 of the most promising bacteria belonged to
bifidobacteria and lactobacilli. Based on our text min-
ing results and from reports of their increasing abun-
dance in healthy babies from 4 to 12 months of age
[12], Akkermansia muciniphila and Faecalibacterium
prausnitzii were also selected as potential “probiotics”
in our study. General literature mining revealed the
presence of Bifidobacterium angulatum in Japanese
children at 3 years of age [13], and Haarman and
Knol [14] found this species harbored by German
infants between 28 and 90 days of age, and possible
relations with feeding mode: B. angulatum seems to
be associated with breast-feeding rather than formula
feeding. Bifidobacterium catenulatum was also re-
ported in mother-infant pairs [15, 16]. Both these
strains were able to modulate cytokine secretion when
tested in vitro in peripheral blood mononuclear cells
[17]. We therefore included B. angulatum and B.
catenulatum into our selected microbial list to further
analyze their interactions with other bacteria.
Identification of exogenous prebiotics for the selected
microorganisms (question ii)
For each strain of the 18 selected strains (Table 2), which
for simplicity will be referred to as a “community” the
metabolic model was retrieved from the Virtual Meta-
bolic Human (VMH) database.
The topology of reconstructed metabolic networks was
analyzed with NetSeed to identify exogenously acquired
metabolites, and the nutrient profile of each strain was
inferred (Additional file 4). We noted oxygen (O2) was
included in the requirements of anaerobic bacteria and,
while there are studies reporting exogenous oxygen up-
take by Bifidobacterium spp. [18, 19], this might be
linked to the VMH model reconstruction (see the
“Methods” section). Table 2 shows the number of me-
tabolites identified as exogenous on a network topology
basis and thus putatively corresponding to essential nu-
trients required by each strain.
Our in silico study of this microbial community of
probiotics identified a total of 632 unique exogenous
metabolites which are potentially required for growth
under normal circumstances [20]. Among them, 62 are
Table 1 Combinations of the dictionaries used in text mining to extract sentences showing relationships/co-mentions from public
domain literature
Relationship No. of
PubMed IDs
No. of Sent. Co-mention No. of
PubMed IDs
No. of
Sent.
gut-microbes | immune-related 89 (208) 172 (427) gut-microbes | immune-related
| infection-disease
42 (48) 66 (74)
gut-microbes | infection-disease 108 (316) 185 (564) gut-microbes | immune-related
| chemical-related
19 (74) 25 (132)
gut-microbes | chemical-related 0 (312) 0 (842) gut-microbes | infection-disease
| chemical-related
25 (58) 31 (75)
immune-related | infection-disease 0 (284) 0 (283) immune-related | infection-disease
| chemical-related
3 (7) 3 (49)
immune-related | chemical-related 0 (185) 0 (185) gut-microbes | immune-related
| infection-disease | chemical-related
2 (7) 2 (9)
infection-disease | chemical-related 0 (155) 0 (156)
We constructed four dictionaries based on four concepts as described in the “Methods” section. The “Relationship” column shows the combinations of two
dictionaries from the two concepts that were analyzed by natural language processing for extracting sentences containing a linguistic relation among both
(Additional file 1). The “Co-mention” column shows the combinations of more than two concepts that were analyzed by natural language processing for extracting
sentences mentioning those concepts (Additional file 2). For both “Relationship” and “Co-mention,” the table gives the number of PubMed IDs and the number of
sentences that are extracted with the text mining pipeline after filtering for publication year (> 1999), human and mice studies, presence of microbial species, exclusion
of pathogens and microbial genus names as described in the “Methods” section. Values before filtering are presented in parenthesis
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essential for all strains, 200 are required by single mi-
crobes in the community, and 398 are shared between
different strains. L. casei subsp. casei BL23 requires the
most of exogenous metabolites (313), while A. mucini-
phila ATCC BAA 835 requires only 208 such essential
metabolites. Interestingly, F. prausnitzii M21 2 shows
highly distinct nutritional requirements compared to
the other microorganisms: it needs 99 compounds for
its metabolism that are not shared with other members
in the community. On the other hand, lactobacilli share
the majority of their necessary metabolites and only 5
are specific for the lactobacilli species considered in
this study.
Grouping probiotics by genera, Bifidobacterium spp.
require 398 nutrients for their growth; among these, 177
are necessary for all nine strains selected in this study,
while 52 are strain-specific. Four hundred eighty-six ex-
ogenous compounds were detected for Lactobacillus
species; 107 are present in the set seed of all seven
strains, while 92 appear to be strain-specific. Five
hundred seventy-six unique metabolites are required by
the bifidobacteria-lactobacilli community; 75 are essen-
tial for all strains, and 73 are strain-specific.
Cooperative metabolic bacteria-bacteria and bacteria-host
interactions (question iii)
Based on graph theory-based methods [21], both
host-microbe and microbe-microbe cooperation was
analyzed for each pair of selected probiotics. The
cooperative and competitive interactions within the se-
lected microbial community were investigated adopting
a reverse ecology approach. We computed the biosyn-
thetic support scores for each microbe-human host pair
and the metabolic complementarity indices as well as
the metabolic competition indices for each microbe-mi-
crobe pair in our community. Figure 3 graphically de-
picts the characteristics of these three scores that are
abbreviated as support, complementarity, and competi-
tion, respectively, in the remaining of the text, for rea-
sons of simplicity.
All probiotic species identified in this study exhibit
low support scores versus the human host, ranging from
0.330 to 0.522, confirming that they are indeed gut com-
mensals rather than parasites. Highest support scores
were obtained for A. muciniphila and L. acidophilus
(0.502 and 0.522), as they are evolved to live in the gut
and hence have higher dependence on the host for
provision of exogenous metabolites.
Our microbial community (lactobacilli, bifidobac-
teria, A. muciniphila, F. prausnitzii, B. angulatum,
and B. catenulatum) is characterized by low comple-
mentarity indices. Lactobacillus paracasei subsp.
paracasei is the most “supported” bacterium, while
the “altruistic” F. prausnitzii complements most of
the community members and is the least “supported.”
Bifidobacterium is the taxon showing the lowest com-
plementarity (0.064 for one pair, mean value 0.190 for
bifidobacteria group), while lactobacilli show the high-
est values (0.243 for one specific pair, mean value
0.127 for lactobacilli group). We infer that B. breve
and Bifidobacterium bifidum is the least complement-
ing pair within bifidobacteria (complementarity 0.006/
0.069), whereas L. rhamnosus and L. casei subsp. casei
and L. paracasei subsp. paracasei show a low poten-
tial for syntrophy within lactobacilli (complementarity
values 0.010/0.150, 0.010/162, respectively). The lacto-
bacilli species most likely to complement each other
are L. acidophilus and Lactobacillus reuteri as they
show the highest complementarity scores (0.243 and
0.164, respectively).
Overall, we can assume complementarity between
lactobacilli and bifidobacteria. Several of our in silico
predictions on microbe metabolic cooperativity are
supported by experimental studies: (i) for example,
Table 2 Putative protective probiotic strains selected. The selection
aims to mimic an immune-enhancing and infection-protective
probiotic community in the infant gut. These strains were
subjected to subsequent network metabolic network analysis.
The “Exogenous metabolite #” column shows the number of
exogenous compounds required by each bacterium
Putative probiotic Exogenous metabolite #
Bifidobacterium adolescentis ATCC 15703 251
Bifidobacterium angulatum DSM 20098 268
Bifidobacterium animalis subsp. lactis
BB 12
248
Bifidobacterium bifidum BGN4 255
Bifidobacterium breve UCC2003 NCIMB8807 258
Bifidobacterium catenulatum DSM 16992 274
Bifidobacterium longum subsp. infantis
ATCC 15697
295
Bifidobacterium longum subsp. longum
CCUG 52486
289
Bifidobacterium pseudocatenulatum
DSM 20438
283
Lactobacillus acidophilus NCFM 220
Lactobacillus casei subsp. casei BL23 313
Lactobacillus fermentum IFO 3956 265
Lactobacillus paracasei subsp. paracasei
ATCC 25302
305
Lactobacillus plantarum WCFS1 308
Lactobacillus reuteri SD2112 ATCC 55730 261
Lactobacillus rhamnosus GG ATCC 53103 276
Akkermansia muciniphila ATCC BAA 835 208
Faecalibacterium prausnitzii M21 2 275
Michelini et al. Microbiome  (2018) 6:171 Page 5 of 18
our finding of B. breve of enhancing L. paracasei
subsp. paracasei (complementarity score 0.239) con-
firms results from in vitro GI models [22]. (ii) F.
prausnitzii shows the highest potential for supporting
requirements of a large number of community mem-
bers (values range 0.036–0.313), from both bifidobac-
teria and lactobacilli. Several authors reported
crossfeeding between (i) acetate-depending butyrate-
producing colon bacteria like F. prausnitzii; (ii)
lactate- and acetate-producing bacteria, like bifidobac-
teria [23–25]; and (iii) lactobacilli [24]. For example,
Rios-Covian et al. [23] showed experimental evidence
of crossfeeding between F. prausnitzii, which requires
acetate for the oligofructose breakdown, and Bifido-
bacterium adolescentis, which produces acetate. B.
adolescentis enhances its growth through consumption
of carbohydrates, which are in turn released during
oligofructose degradation by F. prausnitzii. These in-
teractions are strain-specific and can be either a com-
mensal beneficial relationship or dominated by
competition [26].
A. muciniphila is the least competitive species within
our microbial community with metabolic competition
values ranging from 0.348 of L. reuteri to 0.644 of L.
rhamnosus. Also F. prausnitzii shows values that
characterize them as a non-competitive species. By con-
trast, the closely related species L. casei subsp. casei and
L. paracasei subsp. paracasei, which belong to the same
phylogenetic group [27], are the most competitive pair
(0.947/0.968).
Within bifidobacteria genera, B. adolescentis and Bifi-
dobacterium longum subsp. longum are the least com-
petitive pair (0.703 and 0.811) while Bifidobacterium
pseudocatenulatum and B. catenulatum are the most
competitive pair (0.939 and 0.909) followed by Bifido-
bacterium longum subsp. infantis and B. longum subsp.
longum (0.873 and 0.891). However, species pairs within
the bifidobacteria genus are generally very competitive
(mean competition index of 0.821).
Competition scores for lactobacilli range from 0.419 (L.
reuteri/L. acidophilus pair) to 0.968 (L. paracasei subsp.
paracasei/L. casei subsp. casei pair). The scarce
Fig. 3 For two interacting species, the metabolic network is shown; nodes are metabolites and edges connect substrates to products. Substrates
are colored in red, whereas potential products are in green. The support gives an example of the capacity of a potential eukaryotic host (orange)
to meet the metabolic requirements of a microbe (blue). Complementarity represents exogenously acquired compounds in one species (blue)
that are found in the metabolic network, although not as its feed, of the other species (yellow). Competition shows metabolic competition
between two microbes (blue and yellow) for the same essential metabolites
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competitiveness of the unique homo-fermentative L. acid-
ophilus with other lactobacilli, among other factors, might
be linked to its exclusive fermentation of hexoses to lactic
acid via the Embden-Meyerhof pathway [28]. Indeed, by
contrast, several facultative hetero-fermentative species
(Lactobacillus plantarum, L. rhamnosus, L. casei subsp.
casei, L. paracasei subsp. paracasei), which can ferment
both hexoses and pentoses to lactic acid by the phospho-
gluconate pathway, in our study stand as high competitors
(high competition scores), mainly when paired with L.
acidophilus.
Considering our whole community, A. muciniphila
and F. prausnitzii are the least competitive when paired
with species of other genera, possibly due to their very
distinct set of exogenous metabolites.
A graphical summary of the metabolic complementar-
ity and competition indices is given in Fig. 4a and b, re-
spectively while numeric data for support,
complementarity, and competition is reported in
Additional file 5.
Sourcing exogenous feed metabolites (candidate
prebiotics) from whole foods (question iv)
Among the 632 identified exogenous metabolites, each
needed by at least one of the bacteria in our probiotic
community, there are 218 name-matched compounds in
the food compound list of the Foods database
(FooDB)—candidate prebiotics—in 894 whole foods
(Fig. 5).
The VMH database includes internal metabolites
(1101 out of a total of 1689 metabolites for the 773
gut microbes reported by Magnúsdóttir et al. [29]),
which are not present in other databases: therefore,
these metabolites do not have a match in FooDB.
Moreover, not all metabolites might be present as
compound in foods and for this reason only 218 over
632 metabolites from VMH were found in FooDB.
Interestingly, around 60% of the candidate prebiotics
are present in several common fruits and vegetables:
specifically, 62.7% are present in potatoes, 61.0% in
cucumbers, and 59.3% in spinaches, broccoli, and
common pea. Minerals, such as potassium, sodium,
magnesium, and zinc, are the most commonly found
(between 95.4 and 92.3%), and also vitamins, such as
pyridoxine and β-carotenes, are widely present in most
of the foods (98.5 and 80.7%, respectively).
For further analysis, metabolites were then categorized
into oligosaccharides, monosaccharides, amino acids, vita-
mins, nitrogenous compounds, bioactive substances, and
non-standard nutritive compounds (see Additional file 3:
Supplemental Information 1). For each compound
category, the mean metabolite concentration was calcu-
lated. The relationship between metabolite categories and
foods, after removing non-standard nutritive compounds
(NSN) and removing foods with metabolites below
the limit of quantification (LOQ), is shown in the
circular visualization of Fig. 6a. Figure 6b shows the
Circos between those exogenous metabolites that are
shared among microbes in our community and could be
found in FooDB and the associated foods (13 metabolites
after removing NSN).
A metabolite pathway enrichment analysis was per-
formed for our probiotic community using bStyle [30].
Pathways were considered significant if a hypergeometric
p value lower than 0.05 was obtained. The histogram in
Fig. 7a and the heatmap in Fig. 7b show pathways whose
average overrepresentation significance is less than 0.05
(full results for each microorganism are available in
Additional file 6).
The highest enriched pathways are glyoxylate, dicarboxy-
late, and carbon metabolism (hypergeometric p value of
0.0000119 and 0.0000185, respectively) appearing in all
members of the microbial community selected in our study.
Seven additional pathways are also significantly enriched:
alanine, aspartate, and glutamate metabolism (p = 0.00054);
arginine biosynthesis (p = 0.00084); glycine, serine and
threonine metabolism (p = 0.0021); pyruvate metabolism
(p = 0.0037); microbial metabolism in diverse environ-
ments (p = 0.0058); biosynthesis of antibiotics (p = 0.0061);
and biosynthesis of secondary metabolites (p = 0.0075).
The metabolic pathways of carbohydrates, co-factors,
vitamins, and amino acids are also overrepresented, even
with lower, but still significant, p values. Our analysis also
revealed four pathways that are overrepresented in only
one species each, and these are fatty acid metabolism in L.
plantarum (p = 0.0015), C5-branched dibasic acid metab-
olism in Lactobacillus fermentum (p = 0.0022), starch and
sucrose metabolism in A. muciniphila (p = 0.0023), and ly-
sine degradation in B. longum subsp. longum (p = 0.0027).
The metabolic enrichment analysis confirmed the role of
essential compounds (see Additional file 4) in vitamin B
and amino acid metabolism as growth factors for the se-
lected microbial community of 18 probiotics [31, 32].
The foods were then sorted according to their nutritive
content (Additional file 7 and top 20 foods and their con-
tent in Table 3). At the top of the food list, there is “honey”
that is much enriched in monosaccharides and bioactive
substances, while “Red bell pepper” is characterized by high
amounts of vitamins and amino acids.
Discussion
From the whole body of sentences extracted by the
natural language processing (NLP) pipeline, after a
manual curation, we defined a final gut microbial
sub-community composed of 18 bacteria (Table 2 and
Additional file 3: Table S1) that should as a community
have a beneficial effect on the infant health.
Michelini et al. Microbiome  (2018) 6:171 Page 7 of 18
This prompted us to investigate cooperative and
competitive interactions within the community and its as-
sembly rules applying a reverse ecology approach.
Pair-wise microbial interaction mainly depends on the
environment, into which two considered species are
placed, and the availability of nutrients for their growth
[21]. In a given ecological model with limited nutrient
supply, high complementarity and low competition
b)
a)
Fig. 4 Microbial interaction matrix. a Metabolic complementarity index. For each pair, the complementarity color represents the ability of a
microbe in a column of complementing the nutritional requirements of a species in a row. b Metabolic competition index. For each pair, the
competition color represents the competition that a species in a column can exert on a species in a row
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between two microbial species can suggest potential syn-
trophy or niche complementarity [33], but not necessarily
a coexistence. Niche complementarity may occur in differ-
ent forms according to different relations of predation sus-
ceptibility and resource dependence—including different
forms of the same chemical resource—in a community of
coexisting bacterial species where no one predominates
[34]. Moreover, in closely related species, which are ex-
pected to share specific metabolic traits that help adapt to
a specific habitat, a “habitat filtering” effect may be ob-
served and nutrients available from the environment ra-
ther than crossfeeding between bacteria shape their
community [21]. Nevertheless, lactis acid bacteria can pro-
duce antimicrobial peptides, i.e., bacteriocines, which play
a role in the competitive exclusion of pathogens [35], as
well as interference competition among closely related
species [36], helping producers to colonize and establish a
niche in the environment [37]. In summary, complemen-
tarity and competition metrics could reveal the pressure
of the habitat on the gut community assembly.
Competition and complementarity scores were calculated
for each microbe-microbe pair in the community, and sup-
port scores were calculated for each microbe-human host
pair. The low support scores (~ 0.54) observed between
each microbial strain and the human host supports the
premise that these bacteria are non-pathogenic for humans,
because pathogens (specifically intracellular organisms)
typically show high support values (> 0.7) [21]. Competition
and complementarity were used to capture species interac-
tions within the community; indeed, complementarity is a
measure of potential syntrophy between two species, while
competition index provides a proxy for niches overlap.
Reverse ecology analysis revealed generally low comple-
mentarity (< 0.32) and high competition scores (~ 0.97)
for probiotic species pairs in our microbial community.
We interpreted the results assuming the co-occurrence of
these species in our ecology model. Low complementarity
combined with high competition values observed for bac-
teria pairs belonging to the same genus suggest that these
pairs are close relatives with similar nutrient needs, al-
though the contribution of bacteriocines to modulate the
microbial community could also be a major determinant.
These nutrients are mainly acquired from the environ-
ment rather than via crossfeeding, and, hence, the bacteria
may compete with each other, but do not necessarily ex-
clude one another. Species pairs within the genus bifido-
bacteria are the most competitive and show the lowest
potential for syntrophy; in particular, B. longum subsp.
infantis is the most competitive. The highest competition
scores were obtained for evolutionary closely related pairs.
Among bifidobacteria, B. pseudocatenulatum exerts the
highest competitive interaction when paired with B. cate-
nulatum. Among lactobacilli, L. paracasei subsp. paraca-
sei and L. casei subsp. casei are the most competitive pair.
Interestingly, the least competitive pair among bifidobac-
teria, B. longum subsp. longum and B. adolescentis, con-
sists of species belonging to two phylogenetically distinct
bifidobacteria groups as evident by their distant positions
on the recently reconstructed phylogenetic tree for the
Bifidobacterium taxon [38].
A. muciniphila and F. prausnitzii, which have nutri-
tional needs very different from the others and L. acid-
ophilus, show low competition values. Hence, we can
assume they do not compete with other species in our
Fig. 5 Flow diagram illustrating the process of food selection in FooDB, starting from microbial exogenous metabolites derived from VMH. Of the
632 exogenous metabolites from VMH, 218 corresponded to food compounds from FooDB, which were present in 894 foods. After selection for
LOQ (limit of quantification) and removal of processed foods, alcohol, not clearly defined entries, and foods where at least one of the growth
factor categories (amino acids, vitamins oligo, and monosaccharides) was not detected (LOD: limit of detection), the final foods selected were 152
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Fig. 6 (See legend on next page.)
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selected microbial community. Those species might be
able to grow mutualistically with the other microbes be-
cause their nutritional needs could be met by crossfeed-
ing [33]. While A. muciniphila is not affected by
competitiveness from other microbes, L. acidophilus can
encounter competition from facultative hetero-fermenta-
tive lactobacilli. The low competition and the relatively
high complementarity value of A. muciniphila suggests
its important metabolic role within our selected micro-
bial community; a capable mucin degrader and butyrate
producer, it is involved in crossfeeding supporting the
growth of several other species. Mutualistic interactions
might also occur between some lactobacilli and bifidobac-
teria species pairs, e.g., B. catenulatum, B. longum subsp.
longum, B. longum subsp. infantis, and B. pseudocatenula-
tum. On the other hand, B. breve and B. adolescentis,
which show comparatively high competition values and
are not much involved in potential syntrophic relations
(low complementarity), might exert competitive behavior
in the community. From the results, we might suppose
the possible competition between F. prausnitzii, with Bifi-
dobacterium animalis subsp. lactis and with B. bifidum.
In a nutshell, our reverse ecology analysis provided infor-
mation on potential [39] competitions and/or comple-
mentations between selected species in our community.
These potential outcomes are strain-dependent as re-
vealed by Moens and co-authors [26]. Performing
co-culture fermentations, they found a strain-dependent
interaction between bifidobacteria strains and F. prausnit-
zii, which can be either commensal or competitive de-
pending on the inulin-type fructanse degradation capacity
of the former.
(See figure on previous page.)
Fig. 6 a Circos relations between metabolite categories (oligosaccharides, monosaccharides, amino acids, vitamins, nitrogenous compounds, and
other bioactive substances) required by our selected microbial community and the FooDB-derived foods. Only foods which include all metabolite
categories are shown. The thickness of the arches (colored band) indicates the mean concentration of the metabolite category in associated
foods (1 mg/100 g). b Circos relations between all individual metabolites required by the selected microbial community and the FooDB-derived
foods. Only foods which include more than nine (70%) of community-required metabolites are shown (100 foods in total). The number preceding
the metabolite represents the number of foods that are linked to each category (e.g. 100 means that the metabolite was found in all the 100
identified foods). The length of the arches (colored band) indicates the mean concentration of the metabolite in associated foods (1 mg/100 g)
b)a)
Fig. 7 Metabolite pathway enrichment analysis performed with bStyle. a Histogram: X-axis shows, for each pathway, the mean of the hypergeometric p
value measured for each microorganism; in addition, the number of microorganisms, in which the pathway is overrepresented is given in parenthesis. b
Heatmap: hierarchical clustering of the metabolite pathway enrichment analysis. Color legend: white = pathway not detected in the microbe of interest;
blue = statistical significance (higher blue intensity indicates higher statistical significance for the enriched pathway for the set of selected exogenous
metabolites). The number of microorganisms, in which the pathway is overrepresented, is given in parentheses
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The most over-represented metabolic pathways covered
by these compounds are classified into the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [40] classes
of carbohydrate and amino acid metabolism. Among car-
bohydrates, the galactose metabolism and the pentose
phosphate pathway are enriched by seeds from 10 out of
18 species of the community. The metabolic pathway en-
richment analysis showed D-glucose, sucrose, lactose,
D-sorbitol, galactitol, D-mannose, N-Acetyl-D-galactosa-
mine, alpha-D-galactose, and myo-inositol as associated to
the galactose metabolism. Moreover, the fundamental role
played by microbial growth factors found in the vitamin B
and amino acid metabolism has been underlined.
The aim of introducing prebiotics into the diet is to
stimulate growth of specific indigenous, health-beneficial
gut bacteria, i.e., probiotics. Oligosaccharides are estab-
lished prebiotic substrates because they are carbohy-
drates non-digestible for the human host and can
therefore reach the colon, where they can be selectively
fermented by indigenous beneficial bacteria [41]. Other
substrates used as prebiotics include fibers, cellulose,
hemicellulose, pectins, gums, β-glucans, inulin, fructose-
oligosaccharides, and galacto-oligosaccharides [42]. In
addition to these prebiotics, specific growth factors are
also required by gut microbes, such as B vitamins and
amino acids, essential for both bifidobacteria [31] and
lactobacilli [32]. The metabolic pathway enrichment ana-
lysis shows that most of the exogenous metabolites iden-
tified for lactobacilli and bifidobacteria belong to vitamin
B and amino acid pathways.
In order to inform the design of a prebiotic comple-
mentary infant feeding, the metabolites that are essential
for at least one member of the selected microbial com-
munity (i.e., a total of 632 metabolites) were sourced
into the FooDB. All 218 matching compounds were
associated with a final number of 575 foods. The foods
were sorted (Additional file 7) for facilitating the selec-
tion of the most promising food groups suitable to nour-
ish and support the growth (prebiotic food) of these
selected bacterial species (probiotics). We propose the
top 20 foods (Table 3) that include vegetables and fruits,
which are natural resources of prebiotic compounds,
and moreover, most of them are normally recommended
as complementary foods which can provide infants a
large proportion of micronutrients such as iron, zinc,
phosphorus, magnesium, calcium, and vitamin B6 [43].
Among the foods showing the highest amounts of vita-
mins and amino acids, sweet potato (Kumara) appears
as a practical choice for the formulation of infant com-
plementary foods. Kumara powder is therefore proposed
Table 3 Top 20 foods sorted by decreasing content in vitamins, amino acids, oligosaccharides, monosaccharides, bioactive substances,
and N-compounds and increasing content of NSN. For each food, the mean concentration of each metabolite group (mg/100 g) and
their prebiotic food score are shown. The “Baby Food” category is considered as a “control” and appears in an italic font
Food Vitamins Amino acids Oligosaccharides Bioactive substances N-compounds Mono-saccharide NSNs
Honey 0.38 7.92 426.39 1361.06 0.00 9352.92 0.00
Red bell pepper 543.45 1087.16 3.06 469.98 0.60 388.13 0.02
Eggs 118.84 845.94 115.04 309.86 0.00 23.27 0.00
Cheese 40.45 785.12 176.39 287.93 0.00 14.81 0.00
Turkey 104.03 745.09 16.83 261.86 0.00 29.38 0.00
Sweet potato 591.60 53.05 858.19 203.09 0.00 161.88 0.00
Baby food 59.27 161.20 1867.93 345.37 0.00 619.90 0.00
Cattle (beef, veal) 39.81 782.68 1.18 259.46 0.00 1.99 0.00
Chicken (cock, hen, rooster) 68.66 678.95 12.66 234.91 0.00 16.56 0.00
Spelt 0.41 449.78 956.67 268.16 0.00 135.00 0.00
Domestic pig (piglet, pork) 25.83 680.78 24.34 242.96 0.00 61.64 0.00
Feijoa 0.34 19.17 2056.67 322.34 0.00 658.75 0.00
Oriental wheat 4.83 326.31 1191.67 254.74 0.00 130.00 0.00
Papaya 24.04 17.22 1598.75 356.70 0.00 1197.50 0.00
Peanut 34.67 700.12 477.08 318.34 0.00 143.65 0.01
Sweet basil 181.21 416.94 1.67 215.28 0.00 125.00 0.00
Common walnut 57.81 435.32 405.00 202.80 0.00 21.25 0.00
Italian sweet red pepper 542.47 58.88 4.58 158.18 0.00 519.38 0.00
Pacific sardine 22.97 545.28 5.00 196.02 0.00 50.00 0.00
Mamey sapote 8.45 52.78 745.00 379.17 0.00 1958.75 0.00
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for the pilot clinical trials on infants aged 6–12 months,
where each subject will receive a fixed quantity that
could be mixed with the infant’s complementary foods.
This proof-of-concept of a health benefit-driven, pub-
lic domain mining reverse metabolic approach to identi-
fying candidate pro- and prebiotics and matching food
sources comes with some limitations: For example, we
initially encountered a number of false positives from
the “text mining” due to the complexity of the search
criteria; we have largely overcome this limitation by opti-
mizing our dictionaries and adopting additional filters to
exclude non-relevant articles. For our proof-of-concept,
we deliberately selected a probiotic microbial commu-
nity for gut ecology analysis. However, the infant gut
harbors many more microbes apart from those selected
by us and, hence, the interactions predicted by NetCoo-
perate will be much more complex and may even differ
for our selected community when embedded into a
larger microbial context. Our exogenous metabolite
(prebiotic) identification was targeted towards the strains
that are available in VMH (which again depends mainly
on literature for metabolite reconstruction). From the
literature, it is evident that the prebiotic requirement is
strain-specific. Hence, the full potential of growth-pro-
moting function of this complementary feeding may not
be realized fully in clinical studies conducted with a het-
erogeneous population. Moreover, we encountered some
nomenclature limitations while mapping metabolites be-
tween VMH and FooDB databases, that calls for an in-
creased effort in unifying the identifiers and give
researchers full instruments for the inter-resources data
integration. However, to the best of our knowledge, this is
the first in silico study to identify prebiotics for the growth
of potential probiotics that beneficially impact on the im-
mune system development in infants during weaning.
Conclusion
In conclusion, deploying complex public domain mining
and developing an in silico reverse metabolic approach,
we have (i) constructed probiotic-prebiotic-food correl-
ation matrices that can guide targeted feeding of
immune health-beneficial microbes by weaning food in
infants; (ii) analyzed competition and synergy for (pre-
biotic) nutrients between microbes; and (iii) translated
this information into designing an experimental comple-
mentary feed for infants enrolled in a pilot clinical trial
(http://www.nourishtoflourish.auckland.ac.nz/). The pre-
sented, benefit-oriented microbiome research strategy is
in our opinion nutritionally more actionable than
large-scale descriptive studies in humans and has poten-
tial to be more translational than microbiomics in
rodent models, be they mouse strains, genetically engi-
neered models, or gnotobiotic mice seeded with a lim-
ited set of microbes. Our reverse metabolic pipeline
aimed at leveraging in silico-generated data into clinical
relevance. We have tried to extend from “classical” to
molecular nutrition, with the aim of identifying nutri-
ents, bacteria, and mechanisms that point towards cross-
feeding to improve immune health in infants around
weaning. Our “seeding through feeding” approach differs
fundamentally from classical prebiotic candidate testing
(feeding baby to assert microbial changes and clinical
outcomes). We deliver here the proof-of-concept showing
that the in silico mining indeed yields new pro- and prebi-
otics related to healthy infant immunity but also “positive
controls,” i.e., bacteria we expect to find, such as bifido-
bacteria and lactobacilli. Overall, we present an innovative,
translational systems biology-based methodology to in-
form feeding the infant gut with the optimum prebiotics
to facilitate the growth of beneficial gut bacteria that help
the maturation and development of immune system in
human infants.
Methods
To identify exogenous metabolites required by gut mi-
croorganisms potentially capable of enhancing the im-
mune system against infant infections and to detect
those metabolites in foods/food components, we devel-
oped an integrated pipeline based on literature search-
ing, text mining, reverse metabolic analysis, and food
database exploration.
Identification of immune-protective bacteria (question i)
The workflow for the identification of immune-protective
bacteria is shown in Fig. 1. As a preliminary step, all
context-relevant concepts and keywords were identified.
To prioritize and focus on the research aims, the initial
concepts were organized into four research topics: (a) in-
fant gut microbiome, (b) infant nutrition and microbiome
metabolism, (c) beneficial bacteria supporting immune
system development in infants, and (d) beneficial bacteria
preventing infections in infants. For each topic, a specific
literature query was formulated (see Additional file 3:
Supplemental Information 3 for explanations). To en-
hance the specificity of the queries, keywords specifically
excluding non-human/non-infant data were taken into
consideration. However, some of those keywords, espe-
cially “rat/mice model” and “in vitro” study, occur fre-
quently in literature to provide context for the article.
Hence, those excluding terms were retained in the queries
and used downstream for further manual filtering of the
results, therefore yielding both fewer false-positive and
false-negative articles.
The literature was queried (31 October 2017) for each
of the four research topics to retrieve eligible MEDLINE
abstracts and/or full texts from the PMC Open Access
Subset and PMC Author Manuscript Collection reposi-
tories in PubMed Central. The obtained collection of
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documents, representing the relevant literature corpus
(3673 PubMed IDs), was annotated for key biological
entities, (genes, chemicals, species, DNA mutations,
SNPs, protein mutations, and diseases) using state-of-
the-art biomedical annotation tools: DNorm [44], tmVar
[45], tmChem [46], and GNormPlus [47]. The tools are
the same as utilized in the Pubtator database, which was
deployed for abstract annotations [48], as it allows the
downloading of the data (revision date: 26 June 2017).
All biomedical annotations were retrieved from the
relevant literature corpus of abstracts and full texts and
were manually inspected to improve both understanding
and extent of the potential biological concepts involved
in the weaning period. Pertinent annotations and entity
lists of terms were therefore collected in three dictionaries:
(i) immunity-infant related, (ii) infant infection-disease
related, and (iii) chemical related (Additional file 3:
Supplemental Information 4). Moreover, a fourth micro-
organism dictionary was included with names of human
gut microorganisms. To build this dictionary, a complete
list of microbes at genus level colonizing the human GI
tract was used from the Human Microbiome Project cata-
logue [49]. Two further lactic acid bacteria genera, Oeno-
coccus and Lactococcus, were included. The former,
Oenococcus, which is commonly used in wine fermenta-
tion, was not reported as a gut commensal in the HMP
catalogue, but appears in the Metagenomics of the Human
Intestinal Tract (MetaHit) catalogue, and it is present in
13.5% of subjects of the Danish and Spanish cohort (249
individuals) [50]. The latter, Lactococcus, is a genus dom-
inating in the baby gut microbiota [51]. Furthermore, the
complete list of microbes at species level was downloaded
from the NCBI taxonomy [52] and manually curated for
non-pathogenic species relevant to human gut alone.
Opportunistic pathogens and other non-relevant bacterial
species (those not described at genus level in the Human
Microbiome Project) were excluded from the final list.
The four dictionaries were combined with the litera-
ture corpus and submitted to natural language process-
ing (NLP) methods to extract relevant information for
the four research topics of the project. The CoreNLP
API [53] was used to parse the scientific text in the cor-
pus, and an analytical pipeline was developed to identify
the linguistic relations between the concepts found in
our dictionaries. This is the most important step: all
abstracts and full texts of the literature corpus were
automatically annotated and analyzed to identify rele-
vant linguistic relationships between at least one pair of
terms from each pair of dictionaries. Co-mention
between at least one term related to more than two dic-
tionaries, for all combinations, was also obtained. Table 1
contains the combinations of the four dictionaries used
for NLP relationship and co-mention identification. Out
of 3673 papers in our literature corpus of abstracts and
full texts, the NLP pipeline extracted 348 unique
relevant sentences for relations among two dictionaries
and 129 for co-mentions among three or four dictionar-
ies (an excerpt is shown in Additional file 3: Table S1).
These were manually curated to ensure coherence,
exclude false positives, and identify relevant bacteria at
species/strain level, wherever possible. The latter step
was carried out by exploiting the manually revised
list of human gut microorganisms containing only
non-pathogenic and, putative, probiotic bacteria. Re-
sults from text mining were filtered to exclude arti-
cles published before 2000, sentences from title
journal section and from full texts containing unre-
lated terms (e.g., animals except mice…), “pathogen”
or “not-relevant” species at genera level (e.g., species
level). The role of the identified microorganisms in
supporting the development of the immune system
during early life was manually evaluated to define a
set of putative probiotic bacteria for further analysis.
The evidence on beneficial effects of those microbes was
mainly obtained from clinical studies, with some relevant
articles on in vitro effects being included in the manual
curation process. The full list of sentences identified with
text mining is available in Additional files 1 and 2.
Identification of exogenous metabolites for selected
microorganisms (question ii)
Exogenous metabolites required by beneficial microbes
(putative probiotics) were identified by reverse metabolic
analysis of their metabolic models. The metabolic
models were those published in the Virtual Metabolic
Human [54] database, which contains the in silico meta-
bolic reconstructions of microbes commonly found in
the gut [29]. Those are automatically reconstructed
using ModelSeed [55] starting from the two aerobic bac-
teria Bacillus subtilis and Escherichia coli to evaluate
stoichiometric coefficients for all gram-positive and
gram-negative bacteria respectively and may thus repre-
sents a bias for anaerobic metabolism. A Perl script was
implemented to transform these metabolic models,
which are distributed in the Systems Biology Markup
Language (SBML) format, into text-based metabolic net-
works best suited for the downstream analyses. The
resulting text-based models are directed graphs, repre-
sented with the nodes corresponding to compounds and
the edges corresponding to reactions linking reagents to
products. Furthermore, the tool harmonizes in a detailed
tabular representation all metabolic reactions of each or-
ganism, including enzymes and name identifiers from
the universal metabolite names and CHEBI identifiers
converted using the BiGG Models database [56]. To
infer the nutritional profile of each beneficial microbe,
the metabolic topologies so far obtained were analyzed
with NetSeed [57], a tool to identify the minimal subset
Michelini et al. Microbiome  (2018) 6:171 Page 14 of 18
of nodes (in this case, compounds) that cannot be syn-
thesized from other compounds in the network and
therefore need to be acquired exogenously (see Fig. 3).
Cooperative metabolic interactions between bacteria and
between host and bacteria (question iii)
To deepen the insights into potential ecological micro-
bial interactions between species in our selected com-
munity composed of selected candidate probiotics from
the text mining analysis, a reverse ecology analysis was
applied to predict the ecological structure of this com-
munity. For determining host-microbe and microbe-mi-
crobe cooperative and competitive potential in a
pair-wise manner, NetCooperate [21] and the R package
RevEcoR version 0.99.3 [58], in R version 3.4.1, were
used. Three reverse ecology measures for species inter-
actions were calculated.
The biosynthetic support score provides a measure for
the capacity of a potential host to meet the metabolic
requirements of a microbe and can be also regarded as a
cooperation index [59]. The support represents the frac-
tion of exogenous metabolites of the bacterium, i.e., the
nutrients or precursors that cannot be produced by the
bacterium itself, that are found in the metabolic inter-
action network of the host. Its value ranges from 0, no
cooperation, to 1, full cooperation. While parasites “ego-
istically” exploit the host’s metabolism, commensal bac-
teria have a mutualistic relationship with the host, i.e.,
they both benefit and contribute. High support scores (>
0.75) are reported for parasites whereas low scores (< 0.75)
are reported for commensals [21].
The metabolic complementarity index between two
species measures the ratio (range 0–1) of exogenously
acquired compounds in one species that are found in
the metabolic network, although not as its feed, of the
other species [33]. As such compounds are used by both
species, niche complementarity and syntrophy are likely
to happen and, typically, high complementary species
are able to coexist in contrast to low complementary
ones that do rather not co-occur [21].
The metabolic competition index of two species is the
fraction of compounds exogenously required by both
species and is therefore a measure of potential nutri-
tional competition [33] with values ranging from 0 (no
competition) to 1 (high competition).
Sourcing exogenous metabolites from whole foods
(question iv)
Exogenous compounds, which may inform dietary-based
interventions, were used to interrogate the Canadian
Foods database (FooDB), a resource of whole foods and
food components, as well as their chemistry and biology.
The exact chemical name of the metabolites from VMH
was sourced into the compound database (1689 metabo-
lites for the 773 gut microbes by Magnúsdóttir et al.
[29]), and the identified compounds were linked to
foods. We encountered a limitation in matching the no-
menclatures used in VMH as it provides an extensive
number of metabolites whose names, to the best of the
authors’ knowledge, cannot be retrieved elsewhere (see
the “Results” section for details). The list was manually
filtered to exclude processed foods, alcohol, and those
foods that do not contain clearly defined products (be-
longing to “Other …” categories, see Additional file 3:
Supplemental Information 5). “Baby foods” category (see
Additional file 3: Supplemental Information 2, for de-
scription) was selected as positive control for this study.
A metabolic enrichment set analysis was performed
using the identified exogenous metabolites for which
VMH reported a KEGG identifier. The hypergeometric
distribution is used to evaluate how likely specific
KEGG-available exogenously identified chemical com-
pounds are associated to microbial-specific pathways
and help identify those biological processes and path-
ways that best explain the meaning of the exogenous
compounds. All analyses were performed using the
graphical environment bStyle [30], which automated
and simplified the entire integration and analytical
process (Additional file 3: Figure S1). bStyle also
proved to be much faster than analogous R implemen-
tations. All selected strains were available in the KEGG
database [40], except F. prausnitzii M21 2 that was re-
placed by F. prausnitzii SL3/3 as it belongs to the same
phylogroup [60] and B. longum subsp. infantis CCUG
52486 that was replaced by the closely related B.
longum subsp. longum strain BBMN68 [61]. Only path-
ways in the “metabolism” KEGG class, which includes
biochemical transformations—essential for growth,
reproduction, maintenance of physiological structures,
and response to environmental changes—were consid-
ered in bStyle. A hypergeometric p value lower than
0.05 was defined as the threshold for considering sig-
nificant the enriched pathways.
To better classify the foods for further selection and
trial in infant weaning studies, metabolites were
grouped in seven categories: oligosaccharides,
monosaccharides, vitamins, amino acids, other
bioactive substances, organic nitrogen compounds, and
non-standard nutritive compounds (NSN; see
Additional file 3: Supplemental Information 1). The
NSN category includes trace elements such as nickel,
cadmium, and other heavy metals, plus compounds like
acetaldehyde, ethanol. While some of these trace ele-
ments are co-factors, they exhibit very narrow concen-
tration ranges for bioactivity, above which they can be
or are toxic. Acetaldehyde and ethanol are common
small organic compounds in human metabolism but
Michelini et al. Microbiome  (2018) 6:171 Page 15 of 18
not regarded as nutrients. Furthermore, those sub-
stances have been associated to health complications
[62, 63]. This is why we termed this category as NSN.
The value of metabolite categories was computed, for
each food, as the mean concentration (in mg/100 g) of
their compounds normalized to the range [0–1]. The
sum of the metabolic categories provides a nutritional-
oriented ranking for the foods, and to prioritize foods
rich in essential growth factors (vitamins and amino
acids) that are usually found in very low concentrations,
the weights 10, 8, 6, 4, 2, 1, and − 100 were used
respectively for vitamins, amino acids, oligosaccharides,
bioactive substances, N-compounds, monosaccharides,
and NSNs.
Based on this sorting, the most promising whole-food
source containing several of the identified candidate
prebiotics can be chosen to be incorporated in an ex-
perimental complementary feeding for infants to sup-
port and enhance the growth of immune-protective
beneficial microbes. This experimental weaning food will
be administered in a pilot clinical trial to demonstrate the
role of prebiotic complementary feeding in modulating
the infant gut microbial composition and abundance
(http://www.nourishtoflourish.auckland.ac.nz/).
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